BIOXCEL THERAPEUTICS INC (BTAI)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$0.07-37.11%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · BTAI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 0.7 | 0.6 | 2.3 | 1.4 | 0.4 | — | — | — | — |
| Cost of Revenues | 0.3 | 0.2 | 2.1 | 1.3 | 0.0 | — | — | — | — |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 23.6 | 20.5 | 34.5 | 83.4 | 68.8 | 54.2 | — | — | — |
| R&D Expenses | 21.6 | 30.3 | 30.4 | 84.3 | 91.2 | 52.7 | 58.0 | 25.8 | 14.6 |
| Operating Income | (44.9) | (50.5) | (67.2) | (171.8) | (159.6) | (106.9) | (82.3) | (33.6) | (20.0) |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | 17.0 | 15.1 | 13.3 | 8.2 | 0.0 | 0.0 | — | — |
| Interest & Investment Income | 0.9 | 1.1 | 2.6 | 5.6 | 2.5 | 0.0 | 0.2 | — | — |
| Net Interest Expenses | — | — | — | 7.7 | 5.7 | (0.0) | (0.1) | — | — |
| Income Tax Expense | — | — | — | 0.0 | — | — | — | — | — |
| Net Income | |||||||||
| Net Income | (70.9) | (69.9) | (59.6) | (179.1) | (165.8) | (106.9) | (82.2) | (33.0) | (19.3) |
| Per Share | |||||||||
| Basic EPS | (2.34) | (5.73) | (23.51) | (98.33) | (5.92) | (4.05) | (3.79) | — | — |
| Diluted EPS | (2.34) | (5.73) | (23.51) | (98.33) | (5.92) | (4.05) | (3.79) | — | — |
| Revenue per Share | 0.02 | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 30.3 | 12.2 | 2.5 | 1.8 | 28.0 | 26.4 | 21.7 | — | — |
| Diluted Weighted Avg Shares | 30.3 | 12.2 | 2.5 | 1.8 | 28.0 | 26.4 | 21.7 | — | — |
| Supplemental | |||||||||
| EBITDA | — | — | — | — | — | (106.6) | (82.1) | (33.4) | (19.9) |
| EBIT | (44.9) | (50.5) | (67.2) | (171.8) | (159.6) | (106.9) | (82.3) | (33.6) | (20.0) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.